COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 |
| | | VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY |
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
AbbVie Inc. | Common | 00287Y109 | 9 | 156 | SH | | SOLE | | 156 | 0 | 0 |
ACADIA Pharmaceuticals Inc. | Common | 004225108 | 22,727 | 637,500 | SH | | SOLE | | 637,500 | 0 | 0 |
Accelerate Diagnostics, Inc. | Common | 00430H102 | 5,687 | 264,625 | SH | | SOLE | | 264,625 | 0 | 0 |
Adaptimmune Therapeutics plc | Sponsored ADR | 00653A107 | 3,581 | 296,934 | SH | | SOLE | | 296,934 | 0 | 0 |
Aegerion Pharmaceuticals, Inc. | Note 2.00% 8/15/19 | 00767EAB8 | 8,629 | 13,000,000 | PRN | | SOLE | | 13,000,000 | 0 | 0 |
Affimed NV | Common | N01045108 | 2,095 | 294,213 | SH | | SOLE | | 294,213 | 0 | 0 |
Agilent Technologies, Inc. | Common | 00846U101 | 30,465 | 728,650 | SH | | SOLE | | 728,650 | 0 | 0 |
Akorn, Inc. | Common | 009728106 | 5,419 | 145,235 | SH | | SOLE | | 145,235 | 0 | 0 |
Alere Inc. | Common | 01449J105 | 11,645 | 297,901 | SH | | SOLE | | 297,901 | 0 | 0 |
Alexion Pharmaceuticals, Inc. | Common | 015351109 | 121,471 | 636,805 | SH | | SOLE | | 636,805 | 0 | 0 |
Alkermes plc | Shares | G01767105 | 40,519 | 510,444 | SH | | SOLE | | 510,444 | 0 | 0 |
Allergan plc | Shares | G0177J108 | 127,996 | 409,586 | SH | | SOLE | | 409,586 | 0 | 0 |
Allergan plc | Preferred Convertible | G0177J116 | 5,151 | 5,000 | SH | | SOLE | | 5,000 | 0 | 0 |
Alliqua BioMedical, Inc. | Common | 019621200 | 3,531 | 1,650,000 | SH | | SOLE | | 1,650,000 | 0 | 0 |
Allscripts Healthcare Solutions, Inc. | Common | 01988P108 | 2,670 | 173,600 | SH | | SOLE | | 173,600 | 0 | 0 |
Alnylam Pharmaceuticals, Inc. | Common | 02043Q107 | 12,944 | 137,495 | SH | | SOLE | | 137,495 | 0 | 0 |
Amgen Inc. | Common | 031162100 | 52,212 | 321,640 | SH | | SOLE | | 321,640 | 0 | 0 |
Anacor Pharmaceuticals, Inc. | Common | 032420101 | 12,431 | 110,038 | SH | | SOLE | | 110,038 | 0 | 0 |
ARCA biopharma, Inc. | Common | 00211Y407 | 3,772 | 811,227 | SH | | SOLE | | 811,227 | 0 | 0 |
Ardelyx, Inc. | Common | 039697107 | 11,585 | 639,370 | SH | | SOLE | | 639,370 | 0 | 0 |
Auris Medical Holding AG | Common | H03579101 | 6,202 | 1,268,263 | SH | | SOLE | | 1,268,263 | 0 | 0 |
Baxalta Inc. | Common | 07177M103 | 12,474 | 319,600 | SH | | SOLE | | 319,600 | 0 | 0 |
Baxter International Inc. | Common | 071813109 | 12,193 | 319,600 | SH | | SOLE | | 319,600 | 0 | 0 |
Bellicum Pharmaceuticals, Inc. | Common | 079481107 | 1,216 | 60,000 | SH | | SOLE | | 60,000 | 0 | 0 |
Biogen Inc. | Common | 09062X103 | 138,021 | 450,533 | SH | | SOLE | | 450,533 | 0 | 0 |
BioMarin Pharmaceutical Inc. | Common | 09061G101 | 62,452 | 596,145 | SH | | SOLE | | 596,145 | 0 | 0 |
bluebird bio, Inc. | Common | 09609G100 | 3,169 | 49,345 | SH | | SOLE | | 49,345 | 0 | 0 |
Bristol-Myers Squibb Co. | Common | 110122108 | 13,937 | 202,600 | SH | | SOLE | | 202,600 | 0 | 0 |
Care Capital Properties, Inc. | Common | 141624106 | 2,578 | 84,316 | SH | | SOLE | | 84,316 | 0 | 0 |
Celgene Corporation | Common | 151020104 | 205,225 | 1,713,634 | SH | | SOLE | | 1,713,634 | 0 | 0 |
Celldex Therapeutics, Inc. | Common | 15117B103 | 1,659 | 105,800 | SH | | SOLE | | 105,800 | 0 | 0 |
Cellectis S.A. | Sponsored ADS | 15117K103 | 6,431 | 207,250 | SH | | SOLE | | 207,250 | 0 | 0 |
Centene Corporation | Common | 15135B101 | 7,897 | 120,000 | SH | | SOLE | | 120,000 | 0 | 0 |
Cepheid, Inc. | Common | 15670R107 | 12,186 | 333,590 | SH | | SOLE | | 333,590 | 0 | 0 |
Cepheid, Inc. | Note 1.25% 2/1/21 | 15670RAC1 | 8,894 | 10,000,000 | PRN | | SOLE | | 10,000,000 | 0 | 0 |
Chimerix, Inc. | Common | 16934W106 | 428 | 47,800 | SH | | SOLE | | 47,800 | 0 | 0 |
Cidara Therapeutics, Inc. | Common | 171757107 | 901 | 52,500 | SH | | SOLE | | 52,500 | 0 | 0 |
Community Health Systems, Inc. | Common | 203668108 | 8,078 | 304,472 | SH | | SOLE | | 304,472 | 0 | 0 |
Corsicanto Ltd | Note 3.50% 1/15/32 | 220480AB3 | 13,304 | 14,700,000 | PRN | | SOLE | | 14,700,000 | 0 | 0 |
Cynapsus Therapeutics, Inc. | Common | 23257Y859 | 2,785 | 180,407 | SH | | SOLE | | 180,407 | 0 | 0 |
CytomX Therapeutics, Inc. | Common | 23284F105 | 6,847 | 328,059 | SH | | SOLE | | 328,059 | 0 | 0 |
DBV Technologies S.A. | Sponsored ADR | 23306J101 | 2,382 | 65,600 | SH | | SOLE | | 65,600 | 0 | 0 |
Depomed Inc. | Common | 249908104 | 3,626 | 200,000 | SH | | SOLE | | 200,000 | 0 | 0 |
Dynavax Technologies Corporation | Common | 268158201 | 6,644 | 275,000 | SH | | SOLE | | 275,000 | 0 | 0 |
Eli Lilly & Co | Common | 532457108 | 7,218 | 85,667 | SH | | SOLE | | 85,667 | 0 | 0 |
Endo International plc | Shares | G30401106 | 17,530 | 286,348 | SH | | SOLE | | 286,348 | 0 | 0 |
Endologix Inc. | Common | 29266S106 | 5,455 | 551,000 | SH | | SOLE | | 551,000 | 0 | 0 |
Esperion Therapeutics, Inc. | Common | 29664W105 | 2,288 | 102,800 | SH | | SOLE | | 102,800 | 0 | 0 |
Exelixis, Inc. | Common | 30161Q104 | 5,775 | 1,023,877 | SH | | SOLE | | 1,023,877 | 0 | 0 |
Flamel Technologies SA | Sponsored ADR | 338488109 | 5,791 | 474,288 | SH | | SOLE | | 474,288 | 0 | 0 |
Flex Pharm, Inc. | Common | 33938A105 | 2,896 | 232,600 | SH | | SOLE | | 232,600 | 0 | 0 |
Foamix Pharmaceuticals Ltd. | Shares | M46135105 | 5,289 | 652,145 | SH | | SOLE | | 652,145 | 0 | 0 |
Forward Pharma A/S | Sponsored ADR | 34986J105 | 2,594 | 136,547 | SH | | SOLE | | 136,547 | 0 | 0 |
Galapagos NV | Sponsored ADR | 36315X101 | 1,258 | 20,000 | SH | | SOLE | | 20,000 | 0 | 0 |
GenMark Diagnostics, Inc. | Common | 372309104 | 724 | 93,349 | SH | | SOLE | | 93,349 | 0 | 0 |
Gilead Sciences, Inc. | Common | 375558103 | 235,897 | 2,331,231 | SH | | SOLE | | 2,331,231 | 0 | 0 |
Gilead Sciences, Inc. | Common | ADI0JQKQ6 | 27 | 278 | SH | Call | SOLE | | 278 | 0 | 0 |
GlaxoSmithKline plc | Sponsored ADR | 37733W105 | 11,500 | 285,000 | SH | | SOLE | | 285,000 | 0 | 0 |
Grifols SA | Sponsored ADR | 398438408 | 2,689 | 83,000 | SH | | SOLE | | 83,000 | 0 | 0 |
GW Pharmaceuticals plc | ADS | 36197T103 | 2,083 | 30,000 | SH | | SOLE | | 30,000 | 0 | 0 |
Halozyme Therapeutics, Inc. | Common | 40637H109 | 3,466 | 200,000 | SH | | SOLE | | 200,000 | 0 | 0 |
HCA Holdings, Inc. | Common | 40412C101 | 30,331 | 448,488 | SH | | SOLE | | 448,488 | 0 | 0 |
Healthcare Realty Trust, Inc. | Common | 421946104 | 5,302 | 187,224 | SH | | SOLE | | 187,224 | 0 | 0 |
Heron Therapeutics, Inc. | Common | 427746102 | 5,847 | 219,000 | SH | | SOLE | | 219,000 | 0 | 0 |
Horizon Pharma plc | Common | G4617B105 | 16,250 | 749,900 | SH | | SOLE | | 749,900 | 0 | 0 |
Humana Inc. | Common | 444859102 | 23,081 | 129,300 | SH | | SOLE | | 129,300 | 0 | 0 |
ICON plc | Shares | G4705A100 | 8,928 | 114,900 | SH | | SOLE | | 114,900 | 0 | 0 |
IDEXX Laboratories, Inc. | Common | 45168D104 | 9,651 | 132,352 | SH | | SOLE | | 132,352 | 0 | 0 |
Illumina Inc. | Common | 452327109 | 83,370 | 434,341 | SH | | SOLE | | 434,341 | 0 | 0 |
Impax Laboratories, Inc. | Common | 45256B101 | 14,739 | 344,683 | SH | | SOLE | | 344,683 | 0 | 0 |
Incyte Corporation | Common | 45337C102 | 95,486 | 880,461 | SH | | SOLE | | 880,461 | 0 | 0 |
Inotek Pharmaceuticals Corporation | Common | 45780V102 | 4,815 | 425,000 | SH | | SOLE | | 425,000 | 0 | 0 |
Insmed Incorporated | Common | 457669307 | 2,842 | 156,600 | SH | | SOLE | | 156,600 | 0 | 0 |
Intra-Cellular Therapies, Inc. | Common | 46116X101 | 10,102 | 187,800 | SH | | SOLE | | 187,800 | 0 | 0 |
Ishares Nasdaq Biotechnology ETF | ETF | 464287556 | 19,511 | 57,670 | SH | | SOLE | | 57,670 | 0 | 0 |
Johnson & Johnson | Common | 478160104 | 96,658 | 940,988 | SH | | SOLE | | 940,988 | 0 | 0 |
Juno Therapeutics, Inc. | Common | 48205A109 | 8,003 | 182,000 | SH | | SOLE | | 182,000 | 0 | 0 |
Karyopharm Therapeutics Inc. | Common | 48576U106 | 6,629 | 500,324 | SH | | SOLE | | 500,324 | 0 | 0 |
Kite Pharma, Inc. | Common | 49803L109 | 2,526 | 41,000 | SH | | SOLE | | 41,000 | 0 | 0 |
Lexicon Pharmaceuticals, Inc. | Common | 528872302 | 2,631 | 197,641 | SH | | SOLE | | 197,641 | 0 | 0 |
LTC Properties Inc. | Common | 502175102 | 10,208 | 236,618 | SH | | SOLE | | 236,618 | 0 | 0 |
Mallinckrodt plc | Shares | G5785G107 | 4,620 | 61,900 | SH | | SOLE | | 61,900 | 0 | 0 |
McKesson Corporation | Common | 58155Q103 | 16,343 | 82,862 | SH | | SOLE | | 82,862 | 0 | 0 |
Medical Properties Trust, Inc. | Common | 58463J304 | 18,002 | 1,564,060 | SH | | SOLE | | 1,564,060 | 0 | 0 |
Medivation, Inc. | Common | 58501N101 | 32,257 | 667,300 | SH | | SOLE | | 667,300 | 0 | 0 |
Medtronic PLC | Shares | G5960L103 | 9,565 | 124,344 | SH | | SOLE | | 124,344 | 0 | 0 |
Merck & Co., Inc. | Common | 58933Y105 | 35,976 | 681,097 | SH | | SOLE | | 681,097 | 0 | 0 |
Merrimack Pharmaceuticals, Inc. | Note 4.50% 7/15/20 | 590328AA8 | 2,199 | 1,485,000 | PRN | | SOLE | | 1,485,000 | 0 | 0 |
Merrimack Pharmaceuticals, Inc. | Common | 590328100 | 6,745 | 853,787 | SH | | SOLE | | 853,787 | 0 | 0 |
Molina Healthcare, Inc. | Common | 60855R100 | 20,919 | 347,901 | SH | | SOLE | | 347,901 | 0 | 0 |
Momenta Pharmaceuticals, Inc. | Common | 60877T100 | 2,281 | 153,700 | SH | | SOLE | | 153,700 | 0 | 0 |
Mylan NV | Shares Euro | N59465109 | 28,725 | 531,252 | SH | | SOLE | | 531,252 | 0 | 0 |
Natera, Inc. | Common | 632307104 | 9,529 | 882,358 | SH | | SOLE | | 882,358 | 0 | 0 |
Neurocrine Biosciences, Inc. | Common | 64125C109 | 17,619 | 311,460 | SH | | SOLE | | 311,460 | 0 | 0 |
Nevro Corp. | Common | 64157F103 | 1,688 | 25,000 | SH | | SOLE | | 25,000 | 0 | 0 |
Novartis AG | Sponsored ADR | 66987V109 | 7,976 | 92,700 | SH | | SOLE | | 92,700 | 0 | 0 |
Novavax, Inc. | Common | 670002104 | 3,004 | 358,000 | SH | | SOLE | | 358,000 | 0 | 0 |
Novo Nordisk A/S | ADR | 670100205 | 17,110 | 294,600 | SH | | SOLE | | 294,600 | 0 | 0 |
Omega Healthcare Investors Inc. | Common | 681936100 | 14,451 | 413,116 | SH | | SOLE | | 413,116 | 0 | 0 |
Paratek Pharmaceuticals, Inc. | Common | 699374302 | 14,466 | 762,581 | SH | | SOLE | | 762,581 | 0 | 0 |
Perrigo Company plc | Shares | G97822103 | 5,397 | 37,300 | SH | | SOLE | | 37,300 | 0 | 0 |
Pfizer Inc. | Common | 717081103 | 58,178 | 1,802,291 | SH | | SOLE | | 1,802,291 | 0 | 0 |
Physicians Realty Trust | Common | 71943U104 | 20,751 | 1,230,772 | SH | | SOLE | | 1,230,772 | 0 | 0 |
Pieris Pharmaceuticals, Inc. | Common | 720795103 | 8,812 | 3,848,191 | SH | | SOLE | | 3,848,191 | 0 | 0 |
Puma Biotechnology, Inc. | Common | 74587V107 | 20,400 | 260,200 | SH | | SOLE | | 260,200 | 0 | 0 |
Regeneron Pharmaceuticals, Inc. | Common | 75886F107 | 83,746 | 154,266 | SH | | SOLE | | 154,266 | 0 | 0 |
Retrophin, Inc. | Common | 761299106 | 6,365 | 329,949 | SH | | SOLE | | 329,949 | 0 | 0 |
The RMR Group Inc., Class A | Common | 74967R106 | 107 | 7,441 | SH | | SOLE | | 7,441 | 0 | 0 |
Sabra Health Care REIT Inc. | Common | 78573L106 | 9,229 | 456,190 | SH | | SOLE | | 456,190 | 0 | 0 |
Sage Therapeutics, Inc. | Common | 78667J108 | 5,702 | 97,800 | SH | | SOLE | | 97,800 | 0 | 0 |
Sagent Pharmaceuticals, Inc. | Common | 786692103 | 4,561 | 286,650 | SH | | SOLE | | 286,650 | 0 | 0 |
Sanofi | Sponsored ADR | 80105N105 | 13,008 | 305,000 | SH | | SOLE | | 305,000 | 0 | 0 |
Senior Housing Properties Trust | Common | 81721M109 | 9,950 | 670,504 | SH | | SOLE | | 670,504 | 0 | 0 |
Shire plc | Sponsored ADR | 82481R106 | 35,222 | 171,813 | SH | | SOLE | | 171,813 | 0 | 0 |
St. Jude Medical, Inc. | Common | 790849103 | 15,801 | 255,810 | SH | | SOLE | | 255,810 | 0 | 0 |
Stryker Corporation | Common | 863667101 | 11,519 | 123,940 | SH | | SOLE | | 123,940 | 0 | 0 |
Supernus Pharmaceuticals, Inc. | Note 7.50% 5/1/19 | 868459AB4 | 5,356 | 2,000,000 | PRN | | SOLE | | 2,000,000 | 0 | 0 |
Tenet Healthcare Corporation | Common | 88033G407 | 4,984 | 164,500 | SH | | SOLE | | 164,500 | 0 | 0 |
Tetraphase Pharmaceuticals Inc. | Common | 88165N105 | 1,929 | 192,322 | SH | | SOLE | | 192,322 | 0 | 0 |
Teva Pharmaceutical Industries Ltd. | ADR | 881624209 | 87,579 | 1,334,237 | SH | | SOLE | | 1,334,237 | 0 | 0 |
The Medicines Company | Common | 584688105 | 15,010 | 401,970 | SH | | SOLE | | 401,970 | 0 | 0 |
Thermo Fisher Scientific Inc. | Common | 883556102 | 12,255 | 86,395 | SH | | SOLE | | 86,395 | 0 | 0 |
Ultragenyx Pharmaceutical Inc. | Common | 90400D108 | 9,917 | 88,400 | SH | | SOLE | | 88,400 | 0 | 0 |
UniQure NV | Shares | N90064101 | 2,903 | 175,500 | SH | | SOLE | | 175,500 | 0 | 0 |
United Therapeutics Corporation | Common | 91307C102 | 14,580 | 93,100 | SH | | SOLE | | 93,100 | 0 | 0 |
UnitedHealth Group, Inc. | Common | 91324P102 | 48,127 | 409,100 | SH | | SOLE | | 409,100 | 0 | 0 |
Universal Health Services, Inc. | Common | 913903100 | 8,400 | 70,300 | SH | | SOLE | | 70,300 | 0 | 0 |
Ventas, Inc. | Common | 92276F100 | 20,838 | 369,266 | SH | | SOLE | | 369,266 | 0 | 0 |
Vertex Pharmaceuticals Incorporated | Common | 92532F100 | 130,046 | 1,033,503 | SH | | SOLE | | 1,033,503 | 0 | 0 |
WellCare Health Plans, Inc. | Common | 94946T106 | 6,933 | 88,652 | SH | | SOLE | | 88,652 | 0 | 0 |
Welltower, Inc. | Preferred Convertible | 95040Q203 | 12,182 | 200,000 | PRN | | SOLE | | 200,000 | 0 | 0 |
Xencor, Inc. | Common | 98401F105 | 292 | 20,000 | SH | | SOLE | | 20,000 | 0 | 0 |
Zafgen, Inc. | Common | 98885E103 | 84 | 13,307 | SH | | SOLE | | 13,307 | 0 | 0 |
Zimmer Biomet Holdings, Inc. | Common | 98956P102 | 10,495 | 102,300 | SH | | SOLE | | 102,300 | 0 | 0 |